This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Deepe, G. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Deepe, G. S., Jr

 Previous Article  |  Next Article 

Clinical Microbiology Reviews, 10 1997, 585-596, Vol 10, No. 4
Copyright © 1997 by the American Society for Microbiology. All rights reserved.

Prospects for the development of fungal vaccines

GS Deepe Jr
Division of Infectious Diseases, University of Cincinnati College of Medicine, Ohio 45267-0560, USA. deepegs@ucunix.san.uc.edu

In an era that emphasizes the term "cost-effective," vaccines are the ideal solution to preventing disease at a relatively low cost to society. Much of the previous emphasis has been on childhood scourges such as measles, mumps, rubella, poliomyelitis, and Haemophilus influenzae type b. The concept of vaccines for fungal diseases has had less impact because of the perceived limited problem. However, fungal diseases have become increasingly appreciated as serious medical problems that require recognition and aggressive management. The escalation in the incidence and prevalence of infection has prompted a renewed interest in vaccine development. Herein, I discuss the most recent developments in the search for vaccines to combat fungal infections. Investigators have discovered several inert substances from various fungi that can mediate protection in animal models. The next challenge will be to find the suitable mode of delivery for these immunogens.


This article has been cited by other articles:

  • Saville, S. P., Lazzell, A. L., Chaturvedi, A. K., Monteagudo, C., Lopez-Ribot, J. L. (2009). Efficacy of a Genetically Engineered Candida albicans tet-NRG1 Strain as an Experimental Live Attenuated Vaccine against Hematogenously Disseminated Candidiasis. CVI 16: 430-432 [Abstract] [Full Text]  
  • Casadevall, A., Pirofski, L.-a. (2003). Exploiting the Redundancy in the Immune System: Vaccines Can Mediate Protection by Eliciting 'Unnatural' Immunity. JEM 197: 1401-1404 [Full Text]  
  • Bromuro, C., Torosantucci, A., Chiani, P., Conti, S., Polonelli, L., Cassone, A. (2002). Interplay between Protective and Inhibitory Antibodies Dictates the Outcome of Experimentally Disseminated Candidiasis in Recipients of a Candida albicans Vaccine. Infect. Immun. 70: 5462-5470 [Abstract] [Full Text]  
  • Nisini, R., Romagnoli, G., Gomez, M. J., La Valle, R., Torosantucci, A., Mariotti, S., Teloni, R., Cassone, A. (2001). Antigenic Properties and Processing Requirements of 65-Kilodalton Mannoprotein, a Major Antigen Target of Anti-Candida Human T-Cell Response, as Disclosed by Specific Human T-Cell Clones. Infect. Immun. 69: 3728-3736 [Abstract] [Full Text]  
  • Viudes, A., Perea, S., Lopez-Ribot, J. L. (2001). Identification of Continuous B-Cell Epitopes on the Protein Moiety of the 58-Kilodalton Cell Wall Mannoprotein of Candida albicans Belonging to a Family of Immunodominant Fungal Antigens. Infect. Immun. 69: 2909-2919 [Abstract] [Full Text]  
  • (2001). Coccidioidomycosis in Travelers Returning From Mexico--Pennsylvania, 2000. Arch Dermatol 137: 391-392 [Full Text]  
  • (2000). Coccidioidomycosis in Travelers Returning From Mexico--Pennsylvania, 2000. JAMA 284: 2990-2991 [Full Text]  
  • La Valle, R., Sandini, S., Gomez, M. J., Mondello, F., Romagnoli, G., Nisini, R., Cassone, A. (2000). Generation of a Recombinant 65-Kilodalton Mannoprotein, a Major Antigen Target of Cell-Mediated Immune Response to Candida albicans. Infect. Immun. 68: 6777-6784 [Abstract] [Full Text]  
  • Chang, W. L., Audet, R. G., Aizenstein, B. D., Hogan, L. H., DeMars, R. I., Klein, B. S. (2000). T-Cell Epitopes and Human Leukocyte Antigen Restriction Elements of an Immunodominant Antigen of Blastomyces dermatitidis. Infect. Immun. 68: 502-510 [Abstract] [Full Text]  
  • Gomez, M. J., Maras, B., Barca, A., La Valle, R., Barra, D., Cassone, A. (2000). Biochemical and Immunological Characterization of MP65, a Major Mannoprotein Antigen of the Opportunistic Human Pathogen Candida albicans. Infect. Immun. 68: 694-701 [Abstract] [Full Text]  
  • Chen, L.-C., Goldman, D. L., Doering, T. L., Pirofski, L.-a., Casadevall, A. (1999). Antibody Response to Cryptococcus neoformans Proteins in Rodents and Humans. Infect. Immun. 67: 2218-2224 [Abstract] [Full Text]  
  • Bromuro, C., La Valle, R., Sandini, S., Urbani, F., Ausiello, C. M., Morelli, L., Fe d'ostiani, C., Romani, L., Cassone, A. (1998). A 70-Kilodalton Recombinant Heat Shock Protein of Candida albicans Is Highly Immunogenic and Enhances Systemic Murine Candidiasis. Infect. Immun. 66: 2154-2162 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»